Surgical options in ischemic cardiomyopathy.

Michele De Bonis, Elisabetta Lapenna, Eleonora Ficarra, Giovanni La Canna, Alessandro Verzini, Marco Pagliaro, Alessandro Castiglioni, Francesco Maisano, Lucia Torracca, Stefano Benussi, Ottavio Alfieri

Research output: Contribution to journalArticle

Abstract

The prevalence of ischemic dilated cardiomyopathy in western countries is increasing despite improvements in prevention, diagnosis, and treatment of cardiovascular disease. The management of patients with coronary artery disease and severe left ventricular dysfunction continues to be challenging and the mortality rate with medical therapy alone in this setting remains very high. Since heart transplantation represents a realistic option just for a very small number of patients, in recent years a variety of classic surgical interventions have been improved or optimized to address the complex and multifactorial pathophysiology of the ischemic heart failure picture. Myocardial revascularization, left ventricular restoration, mitral valve repair, passive containment device implantation, and surgical ablation of atrial fibrillation represent some of the "conventional" procedures which are currently in use or under development for the surgical treatment of ischemic cardiomyopathy. For several of them, the exact indications and results are not yet established and significant changes and improvements should reasonably be waited over the next few years. As techniques are refined and more data become available, the optimum surgical strategy for patients with advanced ischemic heart failure is likely to become clearer and more effective.

Original languageEnglish
JournalItalian Heart Journal
Volume5 Suppl 6
Publication statusPublished - May 2004

Fingerprint

Cardiomyopathies
Heart Failure
Myocardial Revascularization
Dilated Cardiomyopathy
Left Ventricular Dysfunction
Heart Transplantation
Mitral Valve
Atrial Fibrillation
Coronary Artery Disease
Cardiovascular Diseases
Therapeutics
Equipment and Supplies
Mortality

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

De Bonis, M., Lapenna, E., Ficarra, E., La Canna, G., Verzini, A., Pagliaro, M., ... Alfieri, O. (2004). Surgical options in ischemic cardiomyopathy. Italian Heart Journal, 5 Suppl 6.

Surgical options in ischemic cardiomyopathy. / De Bonis, Michele; Lapenna, Elisabetta; Ficarra, Eleonora; La Canna, Giovanni; Verzini, Alessandro; Pagliaro, Marco; Castiglioni, Alessandro; Maisano, Francesco; Torracca, Lucia; Benussi, Stefano; Alfieri, Ottavio.

In: Italian Heart Journal, Vol. 5 Suppl 6, 05.2004.

Research output: Contribution to journalArticle

De Bonis, M, Lapenna, E, Ficarra, E, La Canna, G, Verzini, A, Pagliaro, M, Castiglioni, A, Maisano, F, Torracca, L, Benussi, S & Alfieri, O 2004, 'Surgical options in ischemic cardiomyopathy.', Italian Heart Journal, vol. 5 Suppl 6.
De Bonis M, Lapenna E, Ficarra E, La Canna G, Verzini A, Pagliaro M et al. Surgical options in ischemic cardiomyopathy. Italian Heart Journal. 2004 May;5 Suppl 6.
De Bonis, Michele ; Lapenna, Elisabetta ; Ficarra, Eleonora ; La Canna, Giovanni ; Verzini, Alessandro ; Pagliaro, Marco ; Castiglioni, Alessandro ; Maisano, Francesco ; Torracca, Lucia ; Benussi, Stefano ; Alfieri, Ottavio. / Surgical options in ischemic cardiomyopathy. In: Italian Heart Journal. 2004 ; Vol. 5 Suppl 6.
@article{e31a3563a4f543ec9fe139f0d0e00aee,
title = "Surgical options in ischemic cardiomyopathy.",
abstract = "The prevalence of ischemic dilated cardiomyopathy in western countries is increasing despite improvements in prevention, diagnosis, and treatment of cardiovascular disease. The management of patients with coronary artery disease and severe left ventricular dysfunction continues to be challenging and the mortality rate with medical therapy alone in this setting remains very high. Since heart transplantation represents a realistic option just for a very small number of patients, in recent years a variety of classic surgical interventions have been improved or optimized to address the complex and multifactorial pathophysiology of the ischemic heart failure picture. Myocardial revascularization, left ventricular restoration, mitral valve repair, passive containment device implantation, and surgical ablation of atrial fibrillation represent some of the {"}conventional{"} procedures which are currently in use or under development for the surgical treatment of ischemic cardiomyopathy. For several of them, the exact indications and results are not yet established and significant changes and improvements should reasonably be waited over the next few years. As techniques are refined and more data become available, the optimum surgical strategy for patients with advanced ischemic heart failure is likely to become clearer and more effective.",
author = "{De Bonis}, Michele and Elisabetta Lapenna and Eleonora Ficarra and {La Canna}, Giovanni and Alessandro Verzini and Marco Pagliaro and Alessandro Castiglioni and Francesco Maisano and Lucia Torracca and Stefano Benussi and Ottavio Alfieri",
year = "2004",
month = "5",
language = "English",
volume = "5 Suppl 6",
journal = "Italian Heart Journal",
issn = "1129-471X",
publisher = "Societa Italiana di Cardiologia",

}

TY - JOUR

T1 - Surgical options in ischemic cardiomyopathy.

AU - De Bonis, Michele

AU - Lapenna, Elisabetta

AU - Ficarra, Eleonora

AU - La Canna, Giovanni

AU - Verzini, Alessandro

AU - Pagliaro, Marco

AU - Castiglioni, Alessandro

AU - Maisano, Francesco

AU - Torracca, Lucia

AU - Benussi, Stefano

AU - Alfieri, Ottavio

PY - 2004/5

Y1 - 2004/5

N2 - The prevalence of ischemic dilated cardiomyopathy in western countries is increasing despite improvements in prevention, diagnosis, and treatment of cardiovascular disease. The management of patients with coronary artery disease and severe left ventricular dysfunction continues to be challenging and the mortality rate with medical therapy alone in this setting remains very high. Since heart transplantation represents a realistic option just for a very small number of patients, in recent years a variety of classic surgical interventions have been improved or optimized to address the complex and multifactorial pathophysiology of the ischemic heart failure picture. Myocardial revascularization, left ventricular restoration, mitral valve repair, passive containment device implantation, and surgical ablation of atrial fibrillation represent some of the "conventional" procedures which are currently in use or under development for the surgical treatment of ischemic cardiomyopathy. For several of them, the exact indications and results are not yet established and significant changes and improvements should reasonably be waited over the next few years. As techniques are refined and more data become available, the optimum surgical strategy for patients with advanced ischemic heart failure is likely to become clearer and more effective.

AB - The prevalence of ischemic dilated cardiomyopathy in western countries is increasing despite improvements in prevention, diagnosis, and treatment of cardiovascular disease. The management of patients with coronary artery disease and severe left ventricular dysfunction continues to be challenging and the mortality rate with medical therapy alone in this setting remains very high. Since heart transplantation represents a realistic option just for a very small number of patients, in recent years a variety of classic surgical interventions have been improved or optimized to address the complex and multifactorial pathophysiology of the ischemic heart failure picture. Myocardial revascularization, left ventricular restoration, mitral valve repair, passive containment device implantation, and surgical ablation of atrial fibrillation represent some of the "conventional" procedures which are currently in use or under development for the surgical treatment of ischemic cardiomyopathy. For several of them, the exact indications and results are not yet established and significant changes and improvements should reasonably be waited over the next few years. As techniques are refined and more data become available, the optimum surgical strategy for patients with advanced ischemic heart failure is likely to become clearer and more effective.

UR - http://www.scopus.com/inward/record.url?scp=4644363012&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644363012&partnerID=8YFLogxK

M3 - Article

C2 - 15185922

AN - SCOPUS:4644363012

VL - 5 Suppl 6

JO - Italian Heart Journal

JF - Italian Heart Journal

SN - 1129-471X

ER -